US Stock MarketDetailed Quotes

CADL Candel Therapeutics

Watchlist
  • 6.390
  • -0.040-0.62%
Close Apr 26 16:00 ET
  • 6.560
  • +0.170+2.66%
Post 19:59 ET
187.53MMarket Cap-4877P/E (TTM)

Candel Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0.00%125K
0.00%31K
0.00%31K
0.00%31K
0.00%31K
Operating revenue
--0
--0
--0
--0
--0
0.00%125K
0.00%31K
0.00%31K
0.00%31K
0.00%31K
Cost of revenue
Gross profit
Operating expense
10.32%38.39M
28.08%10.35M
-0.71%8.85M
8.91%9.57M
6.70%9.62M
40.46%34.8M
6.06%8.08M
12.40%8.91M
85.83%8.78M
100.51%9.02M
Selling and administrative expenses
-1.24%13.89M
-3.16%3.06M
-14.71%3.02M
-3.11%3.65M
15.67%4.16M
31.73%14.06M
-19.33%3.16M
26.51%3.54M
84.41%3.76M
86.05%3.6M
-General and administrative expense
-1.24%13.89M
-3.16%3.06M
-14.71%3.02M
-3.11%3.65M
15.67%4.16M
31.73%14.06M
-19.33%3.16M
26.51%3.54M
84.41%3.76M
86.05%3.6M
Research and development costs
17.89%24.51M
45.98%7.26M
8.72%5.85M
18.16%5.93M
0.96%5.47M
36.95%20.79M
29.01%4.97M
2.11%5.38M
52.55%5.02M
96.77%5.42M
Other operating expenses
----
----
---12K
---12K
---12K
95.54%-48K
----
----
----
----
Operating profit
-10.72%-38.39M
-28.57%-10.35M
0.36%-8.85M
-9.30%-9.57M
-7.07%-9.62M
-40.67%-34.67M
-6.09%-8.05M
-12.45%-8.88M
-86.39%-8.75M
-101.21%-8.99M
Net non-operating interest income expense
-4.90%-514K
-214.16%-258K
5.11%-167K
47.67%-191K
158.29%102K
-824.53%-490K
2,154.55%226K
-1,157.14%-176K
-2,333.33%-365K
-1,358.33%-175K
Non-operating interest income
70.85%2.08M
-48.38%415K
46.36%502K
547.14%453K
----
--1.22M
--804K
--343K
--70K
----
Non-operating interest expense
51.93%2.6M
16.44%673K
28.90%669K
48.05%644K
----
--1.71M
--578K
--519K
--435K
----
Total other finance cost
----
----
----
----
-158.29%-102K
----
----
----
----
--175K
Other net income (expense)
-94.10%966K
-117.60%-483K
57.45%581K
-97.10%144K
-91.26%724K
243.33%16.37M
-70.17%2.74M
104.47%369K
140.17%4.97M
8.29M
Gain on sale of security
-94.10%966K
-117.60%-483K
57.45%581K
-97.10%144K
-91.26%724K
243.33%16.37M
-70.17%2.74M
104.47%369K
140.17%4.97M
--8.29M
Income before tax
-101.87%-37.94M
-118.28%-11.1M
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
46.24%-8.69M
75.71%-4.15M
80.48%-874K
Income tax
Net income
-101.87%-37.94M
-118.28%-11.1M
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
46.24%-8.69M
75.71%-4.15M
80.48%-874K
Net income continuous Operations
-101.87%-37.94M
-118.28%-11.1M
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
46.24%-8.69M
75.71%-4.15M
80.48%-874K
Minority interest income
Net income attributable to the parent company
-101.87%-37.94M
-118.28%-11.1M
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
46.24%-8.69M
75.71%-4.15M
80.48%-874K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-101.87%-37.94M
-118.28%-11.1M
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
46.24%-8.69M
75.71%-4.15M
80.48%-874K
Basic earnings per share
-101.54%-1.31
-111.11%-0.38
3.33%-0.29
-135.71%-0.33
-900.00%-0.3
65.97%-0.65
-423.57%-0.18
56.52%-0.3
79.67%-0.14
87.46%-0.03
Diluted earnings per share
-101.54%-1.31
-111.11%-0.38
3.33%-0.29
-135.71%-0.33
-900.00%-0.3
65.97%-0.65
-423.57%-0.18
56.52%-0.3
79.67%-0.14
87.46%-0.03
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 000000.00%125K0.00%31K0.00%31K0.00%31K0.00%31K
Operating revenue --0--0--0--0--00.00%125K0.00%31K0.00%31K0.00%31K0.00%31K
Cost of revenue
Gross profit
Operating expense 10.32%38.39M28.08%10.35M-0.71%8.85M8.91%9.57M6.70%9.62M40.46%34.8M6.06%8.08M12.40%8.91M85.83%8.78M100.51%9.02M
Selling and administrative expenses -1.24%13.89M-3.16%3.06M-14.71%3.02M-3.11%3.65M15.67%4.16M31.73%14.06M-19.33%3.16M26.51%3.54M84.41%3.76M86.05%3.6M
-General and administrative expense -1.24%13.89M-3.16%3.06M-14.71%3.02M-3.11%3.65M15.67%4.16M31.73%14.06M-19.33%3.16M26.51%3.54M84.41%3.76M86.05%3.6M
Research and development costs 17.89%24.51M45.98%7.26M8.72%5.85M18.16%5.93M0.96%5.47M36.95%20.79M29.01%4.97M2.11%5.38M52.55%5.02M96.77%5.42M
Other operating expenses -----------12K---12K---12K95.54%-48K----------------
Operating profit -10.72%-38.39M-28.57%-10.35M0.36%-8.85M-9.30%-9.57M-7.07%-9.62M-40.67%-34.67M-6.09%-8.05M-12.45%-8.88M-86.39%-8.75M-101.21%-8.99M
Net non-operating interest income expense -4.90%-514K-214.16%-258K5.11%-167K47.67%-191K158.29%102K-824.53%-490K2,154.55%226K-1,157.14%-176K-2,333.33%-365K-1,358.33%-175K
Non-operating interest income 70.85%2.08M-48.38%415K46.36%502K547.14%453K------1.22M--804K--343K--70K----
Non-operating interest expense 51.93%2.6M16.44%673K28.90%669K48.05%644K------1.71M--578K--519K--435K----
Total other finance cost -----------------158.29%-102K------------------175K
Other net income (expense) -94.10%966K-117.60%-483K57.45%581K-97.10%144K-91.26%724K243.33%16.37M-70.17%2.74M104.47%369K140.17%4.97M8.29M
Gain on sale of security -94.10%966K-117.60%-483K57.45%581K-97.10%144K-91.26%724K243.33%16.37M-70.17%2.74M104.47%369K140.17%4.97M--8.29M
Income before tax -101.87%-37.94M-118.28%-11.1M2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M46.24%-8.69M75.71%-4.15M80.48%-874K
Income tax
Net income -101.87%-37.94M-118.28%-11.1M2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M46.24%-8.69M75.71%-4.15M80.48%-874K
Net income continuous Operations -101.87%-37.94M-118.28%-11.1M2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M46.24%-8.69M75.71%-4.15M80.48%-874K
Minority interest income
Net income attributable to the parent company -101.87%-37.94M-118.28%-11.1M2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M46.24%-8.69M75.71%-4.15M80.48%-874K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -101.87%-37.94M-118.28%-11.1M2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M46.24%-8.69M75.71%-4.15M80.48%-874K
Basic earnings per share -101.54%-1.31-111.11%-0.383.33%-0.29-135.71%-0.33-900.00%-0.365.97%-0.65-423.57%-0.1856.52%-0.379.67%-0.1487.46%-0.03
Diluted earnings per share -101.54%-1.31-111.11%-0.383.33%-0.29-135.71%-0.33-900.00%-0.365.97%-0.65-423.57%-0.1856.52%-0.379.67%-0.1487.46%-0.03
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg